Your browser is no longer supported. Please, upgrade your browser.
ITRM [NASD]
Iterum Therapeutics plc
Index- P/E- EPS (ttm)-1.62 Insider Own0.20% Shs Outstand180.02M Perf Week-9.60%
Market Cap113.26M Forward P/E- EPS next Y-0.23 Insider Trans0.00% Shs Float176.16M Perf Month-10.67%
Income-114.50M PEG- EPS next Q0.12 Inst Own11.20% Short Float1.46% Perf Quarter-70.00%
Sales- P/S- EPS this Y69.50% Inst Trans20.77% Short Ratio0.23 Perf Half Y-63.45%
Book/sh0.26 P/B2.32 EPS next Y17.90% ROA-163.40% Target Price1.00 Perf Year-8.22%
Cash/sh0.50 P/C1.21 EPS next 5Y- ROE- 52W Range0.45 - 2.99 Perf YTD-39.03%
Dividend- P/FCF- EPS past 5Y- ROI- 52W High-79.87% Beta1.21
Dividend %- Quick Ratio2.80 Sales past 5Y- Gross Margin- 52W Low33.70% ATR0.04
Employees7 Current Ratio2.80 Sales Q/Q- Oper. Margin- RSI (14)33.24 Volatility4.03% 5.51%
OptionableNo Debt/Eq0.54 EPS Q/Q104.80% Profit Margin- Rel Volume0.16 Prev Close0.60
ShortableYes LT Debt/Eq0.44 EarningsAug 13 BMO Payout- Avg Volume10.97M Price0.60
Recom3.00 SMA20-8.49% SMA50-26.90% SMA200-52.65% Volume1,839,596 Change-0.12%
May-28-21Upgrade Gabelli & Co Sell → Hold
Mar-15-21Upgrade H.C. Wainwright Neutral → Buy $2.50
Jun-02-20Downgrade RBC Capital Mkts Outperform → Sector Perform $7 → $2
Jan-21-20Downgrade Gabelli & Co Buy → Sell
Dec-11-19Downgrade SVB Leerink Outperform → Mkt Perform
Jun-21-19Initiated H.C. Wainwright Buy $17
Sep-17-21 06:00AM  
Sep-16-21 03:10PM  
Sep-15-21 09:17PM  
08:49PM  
08:15PM  
Sep-14-21 10:00AM  
09:18AM  
Sep-13-21 06:00PM  
05:08PM  
12:40PM  
12:02PM  
10:45AM  
10:00AM  
Sep-10-21 05:45PM  
04:40PM  
11:35AM  
11:00AM  
Sep-09-21 03:00PM  
02:15PM  
11:35AM  
11:00AM  
05:50AM  
Sep-08-21 08:55PM  
08:55AM  
Sep-07-21 08:55PM  
Sep-06-21 08:20AM  
06:12AM  
Sep-03-21 11:00AM  
10:10AM  
05:40AM  
01:03AM  
Sep-02-21 07:45PM  
07:21PM  
11:29AM  
10:00AM  
Sep-01-21 09:00PM  
08:39PM  
06:25PM  
05:02PM  
05:22AM  
Aug-31-21 08:05PM  
03:30PM  
02:00PM  
11:30AM  
11:00AM  
05:40AM  
Aug-30-21 08:05PM  
05:25PM  
05:00PM  
05:40AM  
Aug-29-21 06:40PM  
Aug-27-21 12:00PM  
11:30AM  
Aug-26-21 02:00PM  
01:15PM  
01:11PM  
Aug-25-21 09:05PM  
08:51PM  
08:17PM  
01:15PM  
12:30PM  
10:55AM  
10:00AM  
Aug-24-21 08:45PM  
07:15PM  
05:40AM  
Aug-23-21 10:35PM  
05:40PM  
04:10PM  
04:00PM  
02:15PM  
01:45PM  
05:40AM  
Aug-22-21 07:15PM  
11:40AM  
10:45AM  
Aug-21-21 02:06PM  
Aug-20-21 05:40AM  
Aug-19-21 09:15PM  
02:50PM  
02:15PM  
02:15PM  
11:45AM  
11:05AM  
05:40AM  
Aug-18-21 11:04PM  
08:00PM  
12:50PM  
12:15PM  
11:45AM  
11:00AM  
Aug-17-21 08:00PM  
07:15PM  
12:40PM  
11:33AM  
Aug-16-21 12:35PM  
12:20PM  
11:00AM  
10:21AM  
05:19AM  
Iterum Therapeutics plc, a clinical-stage pharmaceutical company, engages in developing anti-infectives for multi-drug resistant pathogens in Ireland and the United States. It is developing sulopenem, a novel anti-infective compound with oral and IV formulations that is in Phase III clinical trials for the treatment of uncomplicated urinary tract infections, complicated urinary tract infections, and complicated intra-abdominal infections. The company was founded in 2015 and is headquartered in Dublin, Ireland.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
DENNER ALEXANDER J10% OwnerFeb 12Sale2.2710,619,94924,107,2840Feb 12 08:22 PM
DENNER ALEXANDER J10% OwnerFeb 11Sale2.5910,000,00025,900,00010,619,949Feb 12 08:22 PM
Fishman Corey N.President & CEOJan 26Sale1.7385,445147,820322,008Jan 27 07:35 PM
Dunne Michael W.DirectorJan 26Sale1.7333,14357,337256,355Jan 27 07:32 PM
Matthews Judith M.Chief Financial OfficerJan 26Sale1.7333,86858,59228,632Jan 27 07:32 PM
Matthews Judith M.Chief Financial OfficerSep 30Sale1.6456,13092,0530Oct 02 09:00 PM